CM Life Sciences Profit Margin

CM Life Sciences (CMLF) currently reports a profit margin of -23.4% as of June 2026. That compares with 0.39% in the prior-year period — down 6131.3% year over year. That is below the sector sector average of 13.09%. Use the charts on this page to explore CM Life Sciences's profit margin history and peer comparisons.

CM Life Sciences's profit margin decreased from 0.39% to -23.4% — a 6131.3% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

CM Life Sciences's profit margin of -23.4% is lower than the its sector sector average of 13.09%. That is roughly 278.8% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but CM Life Sciences's current -23.4% should be judged against industry norms (sector average: 13.09%) and against CMLF's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -23.4%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 13.09%. From there, open related valuation or income-statement pages for CM Life Sciences, and consider following CMLF for alerts when major investors trade the stock.